Literature DB >> 10651118

Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report.

A Turker1, N Güler.   

Abstract

Therapy related acute myeloid leukemia occurs after exposure to various cytotoxic agents. Among typical chemotherapeutic agents are the alkylating agents and topoisomerase II inhibitors. This type of leukemia has been reported after the use of antimetabolites. We report here a patient who developed therapy related acute myeloid leukemia secondary to the use of 5-fluorouracil.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10651118     DOI： 10.1007/s00282-999-0195-3

Source DB:  PubMed          Journal:  Hematol Cell Ther        ISSN： 1269-3286


  3 in total

1.  A case of therapy-related acute myeloid leukemia following 5-fluorouracil chemotherapy.

Authors:  Hye Jeong Park; Jung-Hye Choi; Kyeong A Lee; Hyun Cheol Kim; Young-Soo Nam; Young-Ha Oh; Woong-Soo Lee
Journal:  Korean J Intern Med       Date:  2012-02-28       Impact factor: 2.884

2.  MLL gene rearrangement in acute myelogenous leukemia after exposure to tegafur/uracil.

Authors:  Toshihiro Fukushima; Nobuyuki Yoshio; Yutaka Noto; Hiroshi Kida
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

3.  Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of Literature.

Authors:  Amandeep Godara; Anupama Kumar; Kenneth B Miller; Muhammad Wasif Saif
Journal:  Cancer Med J       Date:  2020-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.